These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 26653411)

  • 1. Advances in implantable cardioverter defibrillator therapy.
    Rickard J; Wilkoff BL
    Expert Rev Cardiovasc Ther; 2016; 14(3):291-9. PubMed ID: 26653411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.
    Roses-Noguer F; Jarman JW; Clague JR; Till J
    Heart Rhythm; 2014 Jan; 11(1):58-66. PubMed ID: 24120999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality reduction in relation to implantable cardioverter defibrillator programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT).
    Ruwald AC; Schuger C; Moss AJ; Kutyifa V; Olshansky B; Greenberg H; Cannom DS; Estes NA; Ruwald MH; Huang DT; Klein H; McNitt S; Beck CA; Goldstein R; Brown MW; Kautzner J; Shoda M; Wilber D; Zareba W; Daubert JP
    Circ Arrhythm Electrophysiol; 2014 Oct; 7(5):785-92. PubMed ID: 25136077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of ENHANCED Implantable Cardioverter Defibrillator Programming to Reduce Therapies and Improve Quality of Life (from the ENHANCED-ICD Study).
    Mastenbroek MH; Pedersen SS; van der Tweel I; Doevendans PA; Meine M
    Am J Cardiol; 2016 Feb; 117(4):596-604. PubMed ID: 26732419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.
    Wilkoff BL; Williamson BD; Stern RS; Moore SL; Lu F; Lee SW; Birgersdotter-Green UM; Wathen MS; Van Gelder IC; Heubner BM; Brown ML; Holloman KK;
    J Am Coll Cardiol; 2008 Aug; 52(7):541-50. PubMed ID: 18687248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between age and inappropriate implantable cardioverter-defibrillator therapy in MADIT-RIT (Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy).
    Biton Y; Huang DT; Goldenberg I; Rosero S; Moss AJ; Kutyifa V; McNitt S; Strasberg B; Zareba W; Barsheshet A
    Heart Rhythm; 2016 Apr; 13(4):888-93. PubMed ID: 26711799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Causes and Prevention of Inappropriate Implantable Cardioverter-Defibrillator Shocks.
    Kulkarni N; Link MS
    Card Electrophysiol Clin; 2018 Mar; 10(1):67-74. PubMed ID: 29428143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A propensity matched case-control study comparing efficacy, safety and costs of the subcutaneous vs. transvenous implantable cardioverter defibrillator.
    Honarbakhsh S; Providencia R; Srinivasan N; Ahsan S; Lowe M; Rowland E; Hunter RJ; Finlay M; Segal O; Earley MJ; Chow A; Schilling RJ; Lambiase PD
    Int J Cardiol; 2017 Feb; 228():280-285. PubMed ID: 27865198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of diabetes mellitus on inappropriate and appropriate implantable cardioverter-defibrillator therapy and mortality in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT) Trial.
    Ruwald MH; Zareba W; Jons C; Zhang C; Ruwald AC; Olshansky B; McNitt S; Bloch Thomsen PE; Shoda M; Merkely B; Moss AJ; Kutyifa V
    Circulation; 2013 Aug; 128(7):694-701. PubMed ID: 23881862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential role of antitachycardia pacing alerts for the reduction of emergency presentations following shocks in patients with implantable cardioverter-defibrillators: implications for the implementation of remote monitoring.
    Boulé S; Ninni S; Finat L; Botcherby EJ; Kouakam C; Klug D; Marquié C; Brigadeau F; Lacroix D; Kacet S; Guédon-Moreau L
    Europace; 2016 Dec; 18(12):1809-1817. PubMed ID: 26711741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanding the benefits of implantable cardioverter-defibrillator therapy: "is less more"?
    Jackson LR; Daubert JP; Thomas KL
    Prog Cardiovasc Dis; 2012; 54(4):372-8. PubMed ID: 22226007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implantable cardioverter defibrillator therapy and the need for concomitant antiarrhythmic drugs.
    Singh S; Murawski MM
    J Cardiovasc Pharmacol Ther; 2007 Sep; 12(3):175-80. PubMed ID: 17875944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of long-detection interval vs standard-detection interval for implantable cardioverter-defibrillators on antitachycardia pacing and shock delivery: the ADVANCE III randomized clinical trial.
    Gasparini M; Proclemer A; Klersy C; Kloppe A; Lunati M; Ferrer JB; Hersi A; Gulaj M; Wijfels MC; Santi E; Manotta L; Arenal A
    JAMA; 2013 May; 309(18):1903-11. PubMed ID: 23652522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple shocks after upgrade of an implantable cardioverter-defibrillator to a cardiac resynchronization therapy-defibrillator device.
    Francisco GM; Sharma S; Dougherty AH; Kantharia BK
    Cardiol J; 2009; 16(5):473-6. PubMed ID: 19753529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm study.
    Powell BD; Saxon LA; Boehmer JP; Day JD; Gilliam FR; Heidenreich PA; Jones PW; Rousseau MJ; Hayes DL
    J Am Coll Cardiol; 2013 Oct; 62(18):1674-1679. PubMed ID: 23810882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-determinable defibrillation threshold and inefficacy of implantable cardioverter/defibrillator shocks due to defective connections of the defibrillator lead terminals in the device header port.
    Maagh P; Trappe HJ; Meissner A
    Europace; 2007 Dec; 9(12):1161-2. PubMed ID: 17913694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel ICD Programming and Inappropriate ICD Therapy in CRT-D Versus ICD Patients: A MADIT-RIT Sub-Study.
    Kutyifa V; Daubert JP; Schuger C; Goldenberg I; Klein H; Aktas MK; McNitt S; Stockburger M; Merkely B; Zareba W; Moss AJ
    Circ Arrhythm Electrophysiol; 2016 Jan; 9(1):e001965. PubMed ID: 26743237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of a discrimination algorithm to reduce inappropriate shocks with a subcutaneous implantable cardioverter-defibrillator.
    Gold MR; Weiss R; Theuns DA; Smith W; Leon A; Knight BP; Carter N; Husby M; Burke MC
    Heart Rhythm; 2014 Aug; 11(8):1352-8. PubMed ID: 24732366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The subcutaneous implantable cardioverter defibrillator in 2019 and beyond.
    van Dijk VF; Boersma LV
    Trends Cardiovasc Med; 2020 Aug; 30(6):378-384. PubMed ID: 31610949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-traditional implantable cardioverter-defibrillator configurations and insertion techniques: a review of contemporary options.
    Tonko JB; Rinaldi CA
    Europace; 2022 Feb; 24(2):181-192. PubMed ID: 34453529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.